SGLT2 Inhibitors | 合法藥品大搜索

由DCWheeler著作·2020·被引用4次—SGLT2Inhibitors:SlowingofChronicKidneyDiseaseProgressionin...Oralglucose-loweringmedicines,SGLT2inhibitors,Type2diabetes.

The Improving Diabetes Steering Committee thank Steve Bain (Swansea University) for his contribution to the expert panel meeting, which informed the development of this article, and his feedback on the manuscript content.

Professor David C Wheeler has received honoraria, consultancy fees, lecture fees and/or travel support from Amgen, AstraZeneca, Astellas, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Lilly, Napp Pharmaceuticals, Mundipharma, Merck Sharp and Dohme, Takeda and Vifor Fresenius. June James has received funding for provision of educational sessions, resources and attendance at advisory boards from AstraZeneca, BD, Boehringer Ingelheim, Janssen, Lilly, MSD, Napp Pharmaceuticals, Novo Nordisk and Sanofi, Abbott, Mylan, Neon Diagnostics and Nipro. June does not hold any shares in any pharmaceutical company. Dr Dipesh Patel has received educational sponsorship, lecture fees and/or advisory related honoraria from AstraZeneca, Boehringer Ingel...